DCUN1D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.08830002974048E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.19010373672768E-11 |
Normal-vs-Stage2 |
3.82180000000343E-05 |
Normal-vs-Stage3 |
2.65280000000256E-06 |
Normal-vs-Stage4 |
1.227380E-01 |
Stage1-vs-Stage2 |
4.086000E-01 |
Stage1-vs-Stage3 |
4.873800E-01 |
Stage1-vs-Stage4 |
4.168000E-01 |
Stage2-vs-Stage3 |
8.533400E-01 |
Stage2-vs-Stage4 |
6.523200E-01 |
Stage3-vs-Stage4 |
5.872400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.22660000437358E-08 |
Normal-vs-AfricanAmerican |
1.28749999550593E-08 |
Normal-vs-Asian |
7.563800E-03 |
Caucasian-vs-AfricanAmerican |
6.469200E-01 |
Caucasian-vs-Asian |
8.911600E-01 |
AfricanAmerican-vs-Asian |
7.384800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.58302276737277E-12 |
Normal-vs-Female |
1.162110E-03 |
Male-vs-Female |
6.993100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.58241999999031E-05 |
Normal-vs-Extreme_Weight |
1.76414438612937E-12 |
Normal-vs-Obese |
1.04339999995595E-06 |
Normal-vs-Extreme_Obese |
1.741280E-03 |
Normal_Weight-vs-Extreme_Weight |
1.806560E-01 |
Normal_Weight-vs-Obese |
6.260600E-01 |
Normal_Weight-vs-Extreme_Obese |
8.650000E-01 |
Extreme_Weight-vs-Obese |
1.448420E-02 |
Extreme_Weight-vs-Extreme_Obese |
2.249400E-01 |
Obese-vs-Extreme_Obese |
9.165400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.380700E-04 |
Normal-vs-Age(41-60Yrs) |
4.56729999998018E-06 |
Normal-vs-Age(61-80Yrs) |
3.41780048707108E-10 |
Normal-vs-Age(81-100Yrs) |
2.78250000818048E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.347600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.707600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.595980E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.210500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.797700E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.890300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.78179709770166E-11 |
Normal-VS-Type2 PRCC |
3.36369999631714E-08 |
Normal-VS-KIRP CIMP |
2.658400E-01 |
Normal-VS-Unclassified PRCC |
5.256400E-03 |
Type1 PRCC-VS-Type2 PRCC |
9.838800E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.354400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.234020E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.214100E-02 |
Type2 PRCC-VS-Unclassified PRCC |
1.463430E-01 |
KIRP CIMP-VS-Unclassified PRCC |
6.556400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.95172783385078E-12 |
Normal-vs-N1 |
8.589700E-04 |
Normal-vs-N2 |
8.274000E-01 |
N0-vs-N1 |
3.716100E-02 |
N0-vs-N2 |
4.440000E-01 |
N1-vs-N2 |
6.687600E-01 |
|
|